がん化学療法における副作用の解析―５‐ＨＴ３拮抗剤併用による便秘の発生について―:-5-HT3 拮抗剤併用による便秘の発生について-
スポンサーリンク
概要
- 論文の詳細を見る
In order to prevent nausea and vomiting associated with cancer chemotherapy,5-HT3 antagonists are widely used.However,we noticed that the incidence of constipation following the co-administration of anticancer agents and 5-HT3 antagonists in chemotherapy seemed to be higher than stated in the package inserts.To investigate this further,we sent a questionnaire regarding constipation to patients who received cancer-chemotherapy at our hospital in which 5-HT3 antagonists had been co-administered.We also investigated the degree of satisfaction of patients with the measures we took against constipation.The incidence of constipation was high (68%) on the day of cancer chemotherapy in which 5-HT3 antagonists were coadministered,or on the following day.The incidence of constipation without the co-administration of 5-HT3 antagonists was 6%.Among patients who experienced loss of appetite after cancer chemotherapy,63% complained of constipation.There was a significant difference in the incidence of constipation between patients with loss of appetite and those with no loss of appetite.We feel that the high incidence of constipation following cancer chemotherapy was caused by the combination of the 5- HT3 antagonists and a decreased food intake.Among patients with loss of appetite,18% had difficulty in getting over the constipation and this suggests that the resulting lowered QOL could hinder the continuation of chemotherapy.We therefore consider that it is important to reduce adverse reactions in chemotherapy by administering preventive drugs thereby improving QOL.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)